ACE and coronary artery disorder: Braunwald et al. showed that the use of RASi was not associated with therapeutic benefits in patients with stable coronary heart disease and standard medical therapy in the Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial (13).